Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 6.2B | 6.0B | 6.1B | 6.1B |
Cost of revenue | 3.3B | 3.3B | 3.3B | 3.3B |
Gross profit | 2.8B | 2.7B | 2.8B | 2.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | -13M | — | — |
Other operating expenses | 319M | 359M | 281M | 354M |
Operating income | 2.5B | 2.4B | 2.5B | 2.4B |
Non operating interest income | ||||
Income | 16M | — | 52M | 0 |
Expense | 335M | 322M | 312M | 314M |
Other income expense | 107M | 78M | 16M | 87M |
Pretax income | 2.3B | 2.1B | 2.3B | 2.2B |
Tax provision | 437M | 501M | 519M | 518M |
Net income | 1.9B | 1.6B | 1.8B | 1.7B |
Basic EPS | 3.2 | 2.7 | 2.9 | 2.8 |
Diluted EPS | 3.2 | 2.7 | 2.9 | 2.8 |
Basic average shares | 594.1M | 601M | 604.2M | 607.6M |
Diluted average shares | 594.8M | 601.9M | 605.2M | 608.6M |
EBITDA | 3.3B | 3.1B | 3.2B | 3.1B |
Net income from continuing op. | 1.9B | 1.6B | 1.8B | 1.7B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |